Benzoquinoline Derivatives: An Attractive Approach to Newly Small Molecules with Anticancer Activity

Int J Mol Sci. 2023 May 1;24(9):8124. doi: 10.3390/ijms24098124.

Abstract

This study presents the synthesis, structural characterization, and in vitro evaluation of anticancer activity of some newly benzo[f]quinoline derivatives. The synthesis is facile and efficient, involving two steps: quaternization of nitrogen heterocycle followed by a [3+2] dipolar cycloaddition reaction. The synthesized compounds were characterized by FTIR, NMR, and X-ray diffraction on monocrystal in the case of compounds 6c and 7c. An in vitro single-dose anticancer assay of eighteen benzo[f]quinoline compounds, quaternary salts, and cycloadducts, was performed. The results showed that the most active compounds were quaternary salts 3d and 3f with aromatic R substituents. Quaternary salt 3d revealed non-selective activity against all types of cancer cells, while salt 3f exhibited a highly selective activity against leukemia cells. Compound 3d also presented remarkable cytotoxic efficiency against four distinct types of cancer cells-namely, non-small cell lung cancer HOP-92, melanoma LOX IMVI, melanoma SK-MEL-5, and breast cancer MDA-MB-468. Compound 3f was selected for five-dose screening. The study also includes SAR correlations.

Keywords: anticancer; benzo[f]quinoline derivatives; cycloadducts; quaternary salts.

MeSH terms

  • Antineoplastic Agents* / chemistry
  • Carcinoma, Non-Small-Cell Lung*
  • Cell Line, Tumor
  • Cell Proliferation
  • Drug Screening Assays, Antitumor
  • Humans
  • Lung Neoplasms*
  • Melanoma*
  • Molecular Structure
  • Quinolines* / chemistry
  • Quinolines* / pharmacology
  • Salts / pharmacology
  • Structure-Activity Relationship

Substances

  • Salts
  • Antineoplastic Agents
  • Quinolines

Grants and funding

This research was funded by a grant of the Romanian Ministry of Education and Research CNCS–UEFISCDI, project number PN–III–P4–IDPCE–2020–0371, within PNCDI III.